PNC Financial Services Group’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.42K Buy
172
+97
+129% +$2.8K ﹤0.01% 4233
2025
Q4
$1.86K Buy
75
+8
+12% +$161 ﹤0.01% 4546
2025
Q3
$1.09K Buy
67
+18
+37% +$255 ﹤0.01% 4655
2025
Q2
$642 Buy
+49
New +$707 ﹤0.01% 4641
2024
Q2
Sell
-4
Closed -$73 4795
2024
Q1
$73 Sell
4
-6
-60% -$95 ﹤0.01% 4652
2023
Q4
$109 Buy
+10
New +$70 ﹤0.01% 4515
2023
Q2
Sell
-202
Closed -$1.35K 4773
2023
Q1
$1.35K Hold
202
﹤0.01% 4385
2022
Q4
$1.81K Hold
202
﹤0.01% 4289
2022
Q3
$2K Sell
202
-128
-39% -$1.29K ﹤0.01% 4170
2022
Q2
$2K Buy
+330
New +$2.49K ﹤0.01% 4192

Other funds holding EWTX